Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Keros Therapeutics (KROS) over the last 6 years, with Dec 2024 value amounting to $1.8 million.

  • Keros Therapeutics' Amortizatization of Intangibles rose 8.17% to $609,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 49.08%. This contributed to the annual value of $1.8 million for FY2024, which is 17.27% up from last year.
  • According to the latest figures from FY2024, Keros Therapeutics' Amortizatization of Intangibles is $1.8 million, which was up 17.27% from $1.6 million recorded in FY2023.
  • Keros Therapeutics' Amortizatization of Intangibles' 5-year high stood at $1.8 million during FY2024, with a 5-year trough of $327,000 in FY2020.
  • Over the past 3 years, Keros Therapeutics' median Amortizatization of Intangibles value was $1.6 million (recorded in 2023), while the average stood at $1.4 million.
  • Data for Keros Therapeutics' Amortizatization of Intangibles shows a peak YoY skyrocketed of 80.96% (in 2022) over the last 5 years.
  • Keros Therapeutics' Amortizatization of Intangibles (Yearly) stood at $327,000 in 2020, then soared by 59.02% to $520,000 in 2021, then spiked by 80.96% to $941,000 in 2022, then surged by 64.93% to $1.6 million in 2023, then climbed by 17.27% to $1.8 million in 2024.